Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MULTIPLE ENDOCRINE NEOPLASIA TYPE 2' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 33 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wohllk, N; Becker, P; Youlton, R; Cote, GJ; Gagel, RF
      Germline mutations of the ret proto-oncogen in Chilean patients with hereditary and sporadic medullary thyroid carcinoma

      REVISTA MEDICA DE CHILE
    2. Modigliani, E; Franc, B; Niccoli-sire, P
      Diagnosis and treatment of medullary thyroid cancer

      BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    3. Dolan, SJ; Russell, CFJ
      Medullary thyroid carcinoma in Northern Ireland, 1967-1997

      ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND
    4. Hansford, JR; Mulligan, LM
      Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis

      JOURNAL OF MEDICAL GENETICS
    5. Modigliani, E
      Medullary thyroid carcinoma

      REVUE DE MEDECINE INTERNE
    6. Tratzmuller, R; Irle, U; Knorr, D; Vogt, H; Hoppner, W; Dralle, H; Heidemann, PH
      Multiple endocrine neoplasia type 2 (MEN2) in children and adolescents

      MONATSSCHRIFT KINDERHEILKUNDE
    7. RAUE F
      GERMAN MEDULLARY-THYROID CARCINOMA MULTIPLE ENDOCRINE NEOPLASIA REGISTRY

      Langenbecks archives of surgery
    8. SHIRAHAMA S; OGURA K; TAKAMI H; ITO K; TOHSEN T; MIYAUCHI A; NAKAMURA Y
      MUTATIONAL ANALYSIS OF THE RET PROTOONCOGENE IN 71 JAPANESE PATIENTS WITH MEDULLARY-THYROID CARCINOMA

      JOURNAL OF HUMAN GENETICS
    9. TAKAHASHI M; ASAI N; IWASHITA T; MURAKAMI H; ITO S
      MOLECULAR MECHANISMS OF DEVELOPMENT OF MULTIPLE ENDOCRINE NEOPLASIA-2BY RET MUTATIONS

      Journal of internal medicine
    10. ROMEO G; CECCHERINI I; CELLI J; PRIOLO M; BETSOS N; BONARDI G; SERI M; YIN L; LERONE M; JASONNI V; MARTUCCIELLO G
      ASSOCIATION OF MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 AND HIRSCHSPRUNG-DISEASE

      Journal of internal medicine
    11. SANSO G; DOMENE HM; IORCANSKY S; BARONTINI M
      EARLY DIAGNOSIS OF MULTIPLE ENDOCRINE NEO PLASIA TYPE-2 BY DETECTION OF MUTATED RET PROTOONCOGENE CARRIERS

      Medicina
    12. DECKER RA; PEACOCK ML
      OCCURRENCE OF MEN 2A IN FAMILIAL HIRSCHSPRUNGS-DISEASE - A NEW INDICATION FOR GENETIC TESTING OF THE RET PROTOONCOGENE

      Journal of pediatric surgery
    13. HALLING KC; BUFILL JA; COTTER M; ARTZ SA; CARPENTER AB; SCHAID D; HARTMANADAMS H; CHANG HH; BOUSTANY MM; FITHIAN L; JHIANG SM; THIBODEAU SN
      AGE-RELATED DISEASE PENETRANCE IN A LARGE MEDULLARY-THYROID CANCER FAMILY WITH A CODON-609 RET GENE MUTATION

      Molecular diagnosis
    14. LORENZO MJ; GISH GD; HOUGHTON C; STONEHOUSE TJ; PAWSON T; PONDER BAJ; SMITH DP
      RET ALTERNATE SPLICING INFLUENCES THE INTERACTION OF ACTIVATED RET WITH THE SH2 AND PTB DOMAINS OF SHC, AND THE SH2 DOMAIN OF GRB2

      Oncogene
    15. KITAMURA Y; GOODFELLOW PJ; SHIMIZU K; NAGAHAMA M; ITO K; KITAGAWA W; AKASU H; TAKAMI H; TANAKA S; WELLS SA
      NOVEL GERMLINE RET PROTOONCOGENE MUTATIONS ASSOCIATED WITH MEDULLARY-THYROID CARCINOMA (MTC) - MUTATION ANALYSIS IN JAPANESE PATIENTS WITH MTC

      Oncogene
    16. MARSH DJ; MULLIGAN LM; ENG C
      RET PROTOONCOGENE MUTATIONS IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 AND MEDULLARY-THYROID CARCINOMA

      Hormone research
    17. CONTEDEVOLX B; SCHUFFENECKER I; NICCOLI P; MAES B; BONEU A; BARBOT N; CORCUFF JB; MURAT A; HENRY JF; MODIGLIANI E
      MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 - MANAGEMENT OF PATIENTS AND SUBJECTS AT RISK

      Hormone research
    18. RODIEN P; JEUNEMAITRE X; DUMONT C; BELDJORD C; PLOUIN PF
      GENETIC ALTERATIONS OF THE RET PROTOONCOGENE IN FAMILIAL AND SPORADICPHEOCHROMOCYTOMAS

      Hormone research
    19. PATRONE G; PULITI A; BOCCIARDI R; RAVAZZOLO R; ROMEO G
      SEQUENCE AND CHARACTERIZATION OF THE RET PROTOONCOGENE 5'-FLANKING REGION - ANALYSIS OF RETINOIC ACID RESPONSIVENESS AT THE TRANSCRIPTIONALLEVEL

      FEBS letters
    20. DECKER RA; PEACOCK ML
      UPDATE ON THE PROFILE OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A RET MUTATIONS - PRACTICAL ISSUES AND IMPLICATIONS FOR GENETIC TESTING

      Cancer
    21. TAKAMI H; HOSODA Y
      CURRENT STATUS OF INHERITED MEDULLARY-THYROID CARCINOMA IN JAPAN

      Oncology Reports
    22. LAIRMORE TC; FRISELLA MM; WELLS SA
      GENETIC TESTING AND EARLY THYROIDECTOMY FOR INHERITED MEDULLARY-THYROID CARCINOMA

      Annals of medicine
    23. NEUMANN HPH; BENDER B; ZAUNER I; BERGER DP; ENG C; BRAUCH H; ZBAR B
      MONOGENETIC HYPERTENSION AND PHEOCHROMOCYTOMA

      American journal of kidney diseases
    24. KOMMINOTH P; MULETTAFEURER S; SAREMASLANI P; KUNZ EK; MATIASGUIU X; HIORT O; SCHRODER S; SEELENTAG WKF; ROTH J; HEITZ PU
      MOLECULAR DIAGNOSIS OF MULTIPLE ENDOCRINE NEOPLASIA (MEN) IN PARAFFIN-EMBEDDED SPECIMENS

      Endocrine pathology
    25. RAUE F; KRAIMPS JL; DRALLE H; COUGARD P; PROYE C; FRILLING A; LIMBERT E; LLENAS LF; NIEDERLE B
      PRIMARY HYPERPARATHYROIDISM IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A

      Journal of internal medicine
    26. BORRELLO MG; SMITH DP; PASINI B; BONGARZONE I; GRECO A; LORENZO MJ; ARIGHI E; MIRANDA C; ENG C; ALBERTI L; BOCCIARDI R; MONDELLINI P; SCOPSI L; ROMEO G; PONDER BAJ; PIEROTTI MA
      RET ACTIVATION BY GERMLINE MEN2A AND MEN2B MUTATIONS

      Oncogene
    27. ENG C; SMITH DP; MULLIGAN LM; HEALEY CS; ZVELEBIL MJ; STONEHOUSE TJ; PONDER MA; JACKSON CE; WATERFIELD MD; PONDER BAJ
      A NOVEL POINT MUTATION IN THE TYROSINE KINASE DOMAIN OF THE RET PROTOONCOGENE IN SPORADIC MEDULLARY-THYROID CARCINOMA AND IN A FAMILY WITH FMTC

      Oncogene
    28. BORDI C
      ENDOCRINE TUMORS OF THE STOMACH

      Pathology research and practice
    29. KOMMINOTH P; KUNZ EK; MATIASGUIU X; HIORT O; CHRISTENSEN G; COLOMER A; ROTH J; HEITZ PU
      ANALYSIS OF RET PROTOONCOGENE POINT MUTATIONS DISTINGUISHES HERITABLEFROM NONHERITABLE MEDULLARY-THYROID CARCINOMAS

      Cancer
    30. DECKER RA
      MOLECULAR-GENETICS OF APUDOMAS

      Seminars in surgical oncology
    31. FUJITA S; SHIN E; NAKAMURA T; KURAHASHI H; KANEDA Y; TANAKA K; MORI T; TAKAI S; NISHISHO I
      CONSTRUCTION OF RADIATION-REDUCED HYBRIDS AND THEIR USE IN MAPPING OFMICROCLONES FROM CHROMOSOME 10P11.2-Q11.2

      Japanese journal of human genetics
    32. SHIN E; FUJITA S; TAKAMI K; KURAHASHI H; KURITA Y; KOBAYASHI T; MORI T; NISHISHO I; TAKAI S
      DELETION MAPPING OF CHROMOSOME-1P AND CHROMOSOME-22Q IN PHEOCHROMOCYTOMA

      Japanese journal of cancer research
    33. GAGEL RF
      THE ROLE OF GENETIC SCREENING IN THE MANAGEMENT OF HEREDITARY MALIGNANCY

      Hormone and Metabolic Research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 04:03:25